"Nazareth Hospital has served Northeast Philadelphia and the surrounding region for over 75 years. In the 1930s, the founding Sisters prepared by sending its members to train at hospitals throughout the country. After six years of preparation, Nazareth Hospital opened on March 9, 1940, at a cost of $800,000 financed by the Sisters, their families and friends. The hospital has grown to serve the varied health needs of our community with programs ranging from maternity and medical/surgical units to radiation therapy, rehabilitation and a transitional care unit. Today, Nazareth continues to be a vital part of the community, and is dedicated to providing the needed access to high-quality health care, delivered with compassion and respect."

During the past decade, Nazareth Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nazareth Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 2 trials, followed by "Johns Hopkins University" with 2 trials sponsored, "Rothman Institute Orthopaedics" with 2 trials sponsored, "National Cancer Institute (NCI)" with 1 trials sponsored and "SWOG Cancer Research Network" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nazareth Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Nazareth Hospital" are "Breast Carcinoma" (2 trials), "Advanced Malignant Solid Neoplasm" (1 trials), "Angina" (1 trials), "Bladder Carcinoma" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Nazareth Hospital" in a lesser frequency.

Most popular intervention types in "Nazareth Hospital" are "Other" (4 trials), "Drug" (3 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Absorbable screw fixation of Lisfranc fracture-dislocations." (1 trials), "Adavosertib" (1 trials), "Afatinib" (1 trials), "Afatinib Dimaleate" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nazareth Hospital" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Nazareth Hospital". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Nazareth Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nazareth Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".